The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of nanoliposomal irinotecan and carboplatin in patients with advanced or metastatic, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma characterized by tissue and liquid next-generation sequencing.
 
Nai-Jung Chiang
No Relationships to Disclose
 
Chien-Feng Li
No Relationships to Disclose
 
Li-Yuan Bai
Honoraria - Ipsen; Ono Pharmaceutical; Taiwan Society for Therapeutic Radiology and Oncology
Consulting or Advisory Role - Amgen; Astellas Pharma
Research Funding - Eisai
 
Chien-Jui Huang
No Relationships to Disclose
 
Chih Chieh Yen
No Relationships to Disclose
 
Chin-Fu Hsiao
No Relationships to Disclose
 
Li-Ching Wu
No Relationships to Disclose
 
Ming Huang Chen
No Relationships to Disclose